APOE and Alzheimer disease: We then prioritized AD genetics-informed master metabolic regulators by integrating scFUMES with Mendelian Randomization (MR) analysis (Fig. 1d) and investigated their paired sensors across AD phenotypes and risk factors, including disease severity, sex, and APOE status (Fig. 1e).